Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ISPE Names Dr. Thomas Zimmer as Vice President of European Operations

Published: Wednesday, November 13, 2013
Last Updated: Wednesday, November 13, 2013
Bookmark and Share
Dr. Zimmer will be responsible for leading ISPE’s business development and advancing strategic relationships in Europe.

Dr. Zimmer began his work by engaging with global Members at ISPE’s Annual Meeting in Washington, DC. When he returns to Europe, Dr. Zimmer will work closely with ISPE’s volunteer and staff advisory teams, industry representatives, regulatory organizations and Member groups to strengthen ISPE’s relationships and deliver increasing value to ISPE’s European stakeholders. Dr. Zimmer will also serve as the primary European liaison to ISPE’s headquarters in Tampa, Fla. USA.

“Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large,” said ISPE President and CEO Nancy S. Berg. “Thomas’s first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world.”

Dr. Zimmer joins ISPE with more than 30 years of experience in the pharmaceutical industry. He is a licensed pharmacist and Qualified Person. Prior to joining ISPE, Dr. Zimmer was Senior Vice President at Boehringer Ingelheim. During his 32 years with the company, he gained experience in development, production, quality and supply chain operations. Prior to becoming Senior Vice President, Dr. Zimmer served as Plant Manager in France, and he was International Project Leader for the Production Alliance Europe. He worked in various cultural environments in North America, South America and several countries in Europe. He holds a PhD in Pharmaceutical Technology from the University of Frankfurt am Main.

In addition to his professional experience, Dr. Zimmer has held numerous advisory posts within the pharmaceutical industry. He is a current member of the ISPE European Forum, a contributor to the ISPE Regulatory and Compliance Committee and a current member and former chair of the ISPE International Leadership Forum. Additionally, he is the former chair of the industrial advisory board of the University of Applied Sciences at the Beuth Institute in Berlin, former chair of the EFPIA Anti-counterfeiting working group, a former member of the WHO IMPACT taskforce, group regulatory enforcement, former chair of the board of directors for the PSI (Pharmaceutical Security Institute) and a former member in the EFPIA manufacturing GMP working group, product lifecycle team, technical development and operations committee TDOC. Dr. Zimmer has been an ISPE Member since 2005.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ISPE Announces Development of New Drug Shortages Prevention Plan
Drug Shortages Prevention Plan for the pharmaceutical and biopharmaceutical industry.
Tuesday, April 29, 2014
ISPE Issues Global Drug Shortage Survey
Preliminary results are expected in June 2013.
Tuesday, February 26, 2013
Risk-based Control Strategies in Pharmaceutical Industries at ISPE Brussels Conference
The conference will be the global launch of the Baseline® Guide: Risk-Based Manufacture of Pharmaceutical Products.
Friday, July 23, 2010
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!